95 related articles for article (PubMed ID: 7951237)
1. Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy.
Passos-Bueno MR; Vainzof M; Marie SK; Zatz M
Hum Mol Genet; 1994 Jun; 3(6):919-22. PubMed ID: 7951237
[TBL] [Abstract][Full Text] [Related]
2. A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene.
Ishigaki C; Patria SY; Nishio H; Yabe M; Matsuo M
Neurology; 1996 May; 46(5):1347-50. PubMed ID: 8628480
[TBL] [Abstract][Full Text] [Related]
3. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
4. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
[TBL] [Abstract][Full Text] [Related]
5. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
[TBL] [Abstract][Full Text] [Related]
6. Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy.
Love DR; Flint TJ; Genet SA; Middleton-Price HR; Davies KE
J Med Genet; 1991 Dec; 28(12):860-4. PubMed ID: 1757963
[TBL] [Abstract][Full Text] [Related]
7. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
8. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
9. Very small dystrophin molecule in a family with a mild form of Becker dystrophy.
Morandi L; Mora M; Bernasconi P; Mantegazza R; Gebbia M; Balestrini MR; Cornelio F
Neuromuscul Disord; 1993 Jan; 3(1):65-70. PubMed ID: 8329891
[TBL] [Abstract][Full Text] [Related]
10. Deletions in the 5' region of dystrophin and resulting phenotypes.
Muntoni F; Gobbi P; Sewry C; Sherratt T; Taylor J; Sandhu SK; Abbs S; Roberts R; Hodgson SV; Bobrow M
J Med Genet; 1994 Nov; 31(11):843-7. PubMed ID: 7853367
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic and immunological analysis of dystrophin of a young patient with X-linked muscular dystrophy.
Ikeya K; Saito K; Hayashi K; Tanaka H; Hagiwara Y; Yoshida M; Yamauchi A; Fukuyama Y; Ishiguro T; Eguchi C
Am J Med Genet; 1992 Jun; 43(3):580-7. PubMed ID: 1605252
[TBL] [Abstract][Full Text] [Related]
12. Sequences of junction fragments in the deletion-prone region of the dystrophin gene.
Love DR; England SB; Speer A; Marsden RF; Bloomfield JF; Roche AL; Cross GS; Mountford RC; Smith TJ; Davies KE
Genomics; 1991 May; 10(1):57-67. PubMed ID: 2045110
[TBL] [Abstract][Full Text] [Related]
13. Southern blot and PCR analyses of dystrophin gene deletions in Japanese patients with Duchenne muscular dystrophy.
Nakajima T; Matsuo M; Nakamura H; Fujiwara Y
Kobe J Med Sci; 1991 Feb; 37(1):21-33. PubMed ID: 1921260
[TBL] [Abstract][Full Text] [Related]
14. Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy.
Mirabella M; Galluzzi G; Manfredi G; Bertini E; Ricci E; De Leo R; Tonali P; Servidei S
Neurology; 1998 Aug; 51(2):592-5. PubMed ID: 9710043
[TBL] [Abstract][Full Text] [Related]
15. Are there ethnic differences in deletions in the dystrophin gene?
Banerjee M; Verma IC
Am J Med Genet; 1997 Jan; 68(2):152-7. PubMed ID: 9028449
[TBL] [Abstract][Full Text] [Related]
16. Detection of DMD gene deletions in Thai children patients.
Kamolsilp M; Paditaporn R; Noonai A; Wasant P
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():172-4. PubMed ID: 8629100
[TBL] [Abstract][Full Text] [Related]
17. Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD.
Roest PA; Bout M; van der Tuijn AC; Ginjaar IB; Bakker E; Hogervorst FB; van Ommen GJ; den Dunnen JT
J Med Genet; 1996 Nov; 33(11):935-9. PubMed ID: 8950674
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
[TBL] [Abstract][Full Text] [Related]
19. A small intraexonic deletion within the dystrophin gene suggests a possible mechanism of mutagenesis.
Robinson DO; Bunyan DJ; Gabb HA; Temple IK; Yau SC
Hum Genet; 1997 May; 99(5):658-62. PubMed ID: 9150736
[TBL] [Abstract][Full Text] [Related]
20. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
